Diferencia entre revisiones de «Template:Antibacterial Spectra Key»
(Created page with "*'''+''' usually effective clinically or >60% susceptible *'''+/-''' clinical trials lacking or 30-60% susceptible *'''0''' not effective clinically or <30% susceptible *'''bl...") |
(Marked this version for translation) |
||
| (No se muestran 4 ediciones intermedias de 2 usuarios) | |||
| Línea 1: | Línea 1: | ||
*''' | <noinclude><languages/></noinclude> | ||
*'''+ | <translate> | ||
*''' | <!--T:1--> | ||
*''' | *'''S''' susceptible/sensitive (usually) | ||
*'''I''' intermediate (variably susceptible/resistant) | |||
*'''R''' resistant (or not effective clinically) | |||
*'''S+''' synergistic with cell wall antibiotics | |||
*'''U''' sensitive for UTI only (non systemic infection) | |||
*'''X1''' no data | |||
*'''X2''' active in vitro, but not used clinically | |||
*'''X3''' active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis | |||
*'''X4''' active in vitro, but not clinically effective for strep pneumonia | |||
</translate> | |||
Revisión actual - 07:57 23 ene 2026
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia